Close

Form 13F-HR Finepoint Capital LP For: Jun 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. IBM
4. HCP
5. PI
6. LRCX
7. BIIB
8. CNMD
9. BSX
10. NOW


August 12, 2022 10:02 AM EDT

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
Report for the Calendar Year or Quarter Ended: 06-30-2022
Check here if Amendment   Amendment Number:
This Amendment (Check only one.):   is a restatement.
  adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Finepoint Capital LP
Address: 500 BOYLSTON STREET
24TH FLOOR
BOSTON , MA02116
Form 13F File Number: 028-16580

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Stacy L. Vezina
Title: General Counsel
Phone: 617-336-2212
Signature, Place, and Date of Signing:
/s/ Stacy L. Vezina Boston , MA 08-12-2022
[Signature] [City, State] [Date]
Report Type (Check only one.):
X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
  13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
  13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 60
Form 13F Information Table Value Total: 289,206
(thousands)
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
Form 13F File Number Name

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
No. Form 13F File Number Name

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108 9,964 707,200 SH SOLE 707,200 0 0
AfterNext HealthTech Acquisition Corp *W EXP 99/99/999 G01109126 70 366,666 SH SOLE 366,666 0 0
Algoma Stl Group Inc COM 015658107 33,376 3,716,732 SH SOLE 3,716,732 0 0
AMICUS THERAPEUTICS INC COM 03152W109 21,597 2,010,900 SH SOLE 2,010,900 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106 14,398 318,400 SH SOLE 318,400 0 0
ARCUS BIOSCIENCES INC COM 03969F109 13,557 535,000 SH SOLE 535,000 0 0
Ares Acquisition Corp *W EXP 99/99/999 G33032122 116 504,706 SH SOLE 504,706 0 0
ARGENX SE SPONSORED ADR 04016X101 20,005 52,800 SH SOLE 52,800 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101 14,827 159,500 SH SOLE 159,500 0 0
Berenson Acquisition Corp I *W EXP 08/01/202 083690115 121 862,499 SH SOLE 862,499 0 0
Bilander Acquisition Corp *W EXP 05/19/202 09001T114 55 183,749 SH SOLE 183,749 0 0
Bridgetown Holdings Ltd *W EXP 09/30/202 G1355U121 206 895,000 SH SOLE 895,000 0 0
Catalyst Partners Acquisition *W EXP 05/12/202 G19550121 71 336,666 SH SOLE 336,666 0 0
Churchill Capital Corp V *W EXP 10/29/202 17144T115 202 612,000 SH SOLE 612,000 0 0
Churchill Capital Corp VI *W EXP 02/17/202 17143W119 184 540,000 SH SOLE 540,000 0 0
Churchill Capital Corp VII *W EXP 02/29/202 17144M110 191 548,000 SH SOLE 548,000 0 0
Cohn Robbins Holdings Corp *W EXP 08/28/202 G23726113 389 904,000 SH SOLE 904,000 0 0
Compass Digital Acquisition Corp *W EXP 09/29/202 G2476C123 115 459,906 SH SOLE 459,906 0 0
Concord Acquisition Corp II *W EXP 99/99/999 20607U116 90 408,333 SH SOLE 408,333 0 0
Conyers Park III Acquisition Corp *W EXP 08/12/202 21289P110 166 571,666 SH SOLE 571,666 0 0
Corsair Partnering Corp *W EXP 07/06/202 G2540H116 67 334,666 SH SOLE 334,666 0 0
CYTOKINETICS INC COM 23282W605 16,480 419,433 SH SOLE 419,433 0 0
Equity Distribution Acquisitio *W EXP 09/09/202 29465E114 69 669,000 SH SOLE 669,000 0 0
First Light Acquisition Group Inc *W EXP 03/14/202 320703119 59 655,200 SH SOLE 655,200 0 0
Fortress Capital Acquisition C *W EXP 99/99/999 G36427121 71 392,000 SH SOLE 392,000 0 0
Fortress Value Acquisition Cor *W EXP 12/31/202 34964G115 41 225,000 SH SOLE 225,000 0 0
Fortress Value Acquisition Cor *W EXP 03/18/202 34964K116 57 306,513 SH SOLE 306,513 0 0
GALAPAGOS NV SPON ADR 36315X101 14,475 259,400 SH SOLE 259,400 0 0
GLOBAL BLOOD THERAPEUTICS IN COM 37890U108 15,144 474,000 SH SOLE 474,000 0 0
GLOBAL BUSINESS TRAVEL GROUP *W EXP 99/99/9999 37890B118 959 913,000 SH SOLE 913,000 0 0
Gores Technology Partners II Inc *W EXP 03/16/202 38287L115 198 450,691 SH SOLE 450,691 0 0
Gores Technology Partners Inc *W EXP 03/16/202 382870111 105 201,000 SH SOLE 201,000 0 0
Health Assurance Acquisition C *W EXP 11/12/202 42226W117 87 643,000 SH SOLE 643,000 0 0
Home Plate Acquisition Corp *W EXP 09/30/202 43734R111 124 690,000 SH SOLE 690,000 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100 10,601 960,200 SH SOLE 960,200 0 0
IVERIC BIO INC COM 46583P102 9,501 987,600 SH SOLE 987,600 0 0
Jaws Hurricane Acquisition Corp *W EXP 03/26/202 47201B111 139 387,249 SH SOLE 387,249 0 0
KKR Acquisition Holdings I Corp *W EXP 99/99/999 48253T117 212 588,547 SH SOLE 588,547 0 0
Levere Holdings Corp *W EXP 03/09/202 G5462L122 22 274,999 SH SOLE 274,999 0 0
Marblegate Acquisition Corp *W EXP 08/31/202 56608A113 74 735,000 SH SOLE 735,000 0 0
MIRATI THERAPEUTICS INC COM 60468T105 14,111 210,200 SH SOLE 210,200 0 0
Music Acquisition Corp/The *W EXP 02/05/202 62752R118 7 75,250 SH SOLE 75,250 0 0
PROTAGONIST THERAPEUTICS INC COM 74366E102 5,815 735,126 SH SOLE 735,126 0 0
PROTHENA CORP PLC SHS G72800108 12,421 457,500 SH SOLE 457,500 0 0
Revolution Healthcare Acquisit *W EXP 12/31/202 76155Y116 108 432,639 SH SOLE 432,639 0 0
Ross Acquisition Corp II *W EXP 02/01/202 G7641C114 68 439,666 SH SOLE 439,666 0 0
SAGE THERAPEUTICS INC COM 78667J108 15,362 475,600 SH SOLE 475,600 0 0
SAREPTA THERAPEUTICS INC COM 803607100 15,817 211,000 SH SOLE 211,000 0 0
Senior Connect Acquisition Cor *W EXP 12/31/202 81723H116 71 1,014,000 SH SOLE 1,014,000 0 0
Simon Property Group Acquisition Holdings Inc *W EXP 02/04/202 82880R111 62 335,200 SH SOLE 335,200 0 0
Skydeck Acquisition Corp *W EXP 05/13/202 G82220115 54 361,756 SH SOLE 361,756 0 0
Social Capital Hedosophia Holdings Corp VI *W EXP 09/26/202 G8251L113 322 671,000 SH SOLE 671,000 0 0
Starry Group Holdings Inc *W EXP 99/99/999 85572U110 276 669,000 SH SOLE 669,000 0 0
Summit Healthcare Acquisition Corp *W EXP 06/03/202 G8566R110 45 489,999 SH SOLE 489,999 0 0
Swiftmerge Acquisition Corp *W EXP 12/13/202 G63836111 54 490,000 SH SOLE 490,000 0 0
TRAVERE THERAPEUTICS INC COM 89422G107 14,158 584,300 SH SOLE 584,300 0 0
ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 12,123 203,200 SH SOLE 203,200 0 0
Warburg Pincus Capital Corp I-A *W EXP 99/99/999 G9461D115 5 14,999 SH SOLE 14,999 0 0
Warburg Pincus Capital Corp I-B *W EXP 99/99/999 G9460M124 34 125,000 SH SOLE 125,000 0 0
Zimmer Energy Transition Acquisition Corp *W EXP 06/16/202 989570114 115 358,270 SH SOLE 358,270 0 0

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings